Titre:
  • A phase I study of BAY 43-9006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced, solid tumors
Auteur:Awada, Ahmad; Hendlisz, Alain; Gil, Thierry; Schwartz, Bertrand; Bartholomeus, Sylvie; de Valeriola, Dominique; Brendel, Erich; Haase, Claus Gert; Piccart-Gebhart, Martine
Informations sur la publication:16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics(2004), European Journal of Cancer, Vol. 2, page (114)
Statut de publication:Publié, 2004
Sujet CREF:Cancérologie
Pharmacologie
Langue:Anglais